Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne C Koff

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1Robert Pejchal, Laura M Walker, Robyn L Stanfield, et al.
Plos Pathogens|May 14, 2009
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titersAnn J Hessell, Eva G Rakasz, Pascal Poignard, et al.
Science (New York, N.Y.)|June 1, 2013
Accelerating next-generation vaccine development for global disease preventionWayne C Koff, Dennis R Burton, Philip R Johnson, et al.
Nature Immunology|February 27, 2004
HIV vaccine design and the neutralizing antibody problemDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Vaccine|April 20, 2013
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of VaccinesWayne C Koff, Nina D Russell, Mark Walport, et al.
Journal of Virology|November 13, 2009
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-LAnn J Hessell, Eva G Rakasz, David M Tehrani, et al.
Plos One|February 23, 2013
N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of functionMarie Pancera, Yongping Yang, Mark K Louder, et al.
Nature Immunology|December 17, 2005
HIV vaccine design: insights from live attenuated SIV vaccinesWayne C Koff, Philip R Johnson, David I Watkins, et al.
Science (New York, N.Y.)|October 10, 2014
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virionsJames B Munro, Jason Gorman, Xiaochu Ma, et al.
Frontiers in Microbiology|October 2, 2012
Somatic Populations of PGT135-137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and BioinformaticsJiang Zhu, Sijy O'Dell, Gilad Ofek, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1Robert Pejchal, Laura M Walker, Robyn L Stanfield, et al.
Plos Pathogens|May 14, 2009
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titersAnn J Hessell, Eva G Rakasz, Pascal Poignard, et al.
Science (New York, N.Y.)|June 1, 2013
Accelerating next-generation vaccine development for global disease preventionWayne C Koff, Dennis R Burton, Philip R Johnson, et al.
Nature Immunology|February 27, 2004
HIV vaccine design and the neutralizing antibody problemDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Vaccine|April 20, 2013
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of VaccinesWayne C Koff, Nina D Russell, Mark Walport, et al.
Journal of Virology|November 13, 2009
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-LAnn J Hessell, Eva G Rakasz, David M Tehrani, et al.
Plos One|February 23, 2013
N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of functionMarie Pancera, Yongping Yang, Mark K Louder, et al.
Nature Immunology|December 17, 2005
HIV vaccine design: insights from live attenuated SIV vaccinesWayne C Koff, Philip R Johnson, David I Watkins, et al.
Science (New York, N.Y.)|October 10, 2014
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virionsJames B Munro, Jason Gorman, Xiaochu Ma, et al.
Frontiers in Microbiology|October 2, 2012
Somatic Populations of PGT135-137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and BioinformaticsJiang Zhu, Sijy O'Dell, Gilad Ofek, et al.
Pageof 7